BR0308713A - Co-esférula de dha e alecrim, e métodos de uso - Google Patents

Co-esférula de dha e alecrim, e métodos de uso

Info

Publication number
BR0308713A
BR0308713A BR0308713-1A BR0308713A BR0308713A BR 0308713 A BR0308713 A BR 0308713A BR 0308713 A BR0308713 A BR 0308713A BR 0308713 A BR0308713 A BR 0308713A
Authority
BR
Brazil
Prior art keywords
dha
rosemary
methods
spherical
improved
Prior art date
Application number
BR0308713-1A
Other languages
English (en)
Inventor
John C Lang
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28675473&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0308713(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of BR0308713A publication Critical patent/BR0308713A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Abstract

"CO-ESFéRULA DE DHA E ALECRIM, E MéTODOS DE USO". A presente invenção refere-se a formulações de esférulas aperfeiçoadas, úteis para inclusão em suplementos dietéticos especializados para manter e melhorar a nutrição ocular. Particularmente, as co-esférulas aperfeiçoadas compreendem DHA (ácido docosa-hexanóico); alecrim e/ou seus componentes; e excipientes.
BR0308713-1A 2002-03-28 2003-03-19 Co-esférula de dha e alecrim, e métodos de uso BR0308713A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36835202P 2002-03-28 2002-03-28
PCT/US2003/008558 WO2003082249A1 (en) 2002-03-28 2003-03-19 Co-beadlet of dha and rosemary and methods of use

Publications (1)

Publication Number Publication Date
BR0308713A true BR0308713A (pt) 2005-01-04

Family

ID=28675473

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0308713-1A BR0308713A (pt) 2002-03-28 2003-03-19 Co-esférula de dha e alecrim, e métodos de uso

Country Status (12)

Country Link
US (2) US20050147698A1 (pt)
EP (1) EP1487418B1 (pt)
JP (2) JP2005527551A (pt)
AR (1) AR039171A1 (pt)
AT (1) ATE398445T1 (pt)
AU (1) AU2003220417B2 (pt)
BR (1) BR0308713A (pt)
CA (1) CA2478154A1 (pt)
DE (1) DE60321669D1 (pt)
DK (1) DK1487418T3 (pt)
HK (1) HK1070558A1 (pt)
WO (1) WO2003082249A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7239755B1 (en) * 1997-07-30 2007-07-03 Lg Electronics Inc. Method of reducing a blocking artifact when coding moving picture
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
US7666449B2 (en) 2001-06-20 2010-02-23 Metaproteomics, Llc Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
US8142819B2 (en) 2002-10-21 2012-03-27 Metaproteomics, Llc Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
AR039170A1 (es) * 2002-03-28 2005-02-09 Bio Dar Ltd Co-granulos de dha y romero y metodos de uso
US20050147698A1 (en) * 2002-03-28 2005-07-07 Alcon, Inc. Co-beadlet of dha and rosemary and methods of use
WO2005039483A2 (en) 2003-05-22 2005-05-06 Metaproteomics, Llc Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
US7914831B2 (en) 2004-02-27 2011-03-29 Metaproteomics, Llc Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
FR2882894B1 (fr) * 2005-03-11 2009-04-03 Larena Sa Composition alimentaire suppletive
EP1928248A4 (en) * 2005-08-09 2009-09-16 Metaproteomics Llp MODULATION OF KINASE PROTEINS USING HOP OR ACACIA PRODUCTS
ES2277557B1 (es) * 2005-12-21 2008-07-01 Proyecto Empresarial Brudy, S.L. Utilizacion de acido docosahexaenoico para el tratamiento del daño celular oxidativo.
AU2008229110A1 (en) 2007-03-19 2008-09-25 Metaproteomics, Llc Methods and compositions for promoting bone and joint health
AU2011211461B2 (en) * 2008-01-11 2011-11-17 U.S. Nutraceuticals, Llc D/B/A Valensa International Chia seed composition
US8652544B2 (en) * 2008-01-11 2014-02-18 U.S. Nutraceuticals, LLC Chia seed composition
US20100159029A1 (en) * 2008-12-23 2010-06-24 Alcon Research, Ltd. Composition and nutritional supplements for improving ocular health and reducing ocular inflammatory response
JP5560017B2 (ja) * 2009-10-13 2014-07-23 旭化成ケミカルズ株式会社 脂肪酸、トリグリセリドまたはその混合物を含むマルチコアマイクロカプセルを含有する錠剤およびその製法
WO2011057183A1 (en) 2009-11-06 2011-05-12 Alcon Research, Ltd. Nutritional supplements for relief of dry eye

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998753A (en) * 1974-08-13 1976-12-21 Hoffmann-La Roche Inc. Water dispersible carotenoid preparations and processes thereof
CH627449A5 (de) * 1977-03-25 1982-01-15 Hoffmann La Roche Verfahren zur herstellung von mikrokristallinem vitamin a-acetat, sowie von trockenen, frei-fliessenden praeparaten, in welchen vitamin a-acetat in mikrokristalliner form vorliegt.
AU552068B2 (en) * 1981-09-21 1986-05-22 Asama Chemical Co. Ltd. Preservation of edible oils
US4670247A (en) * 1983-07-05 1987-06-02 Hoffman-Laroche Inc. Process for preparing fat-soluble vitamin active beadlets
DK88692D0 (da) * 1992-07-06 1992-07-06 Danochemo As Fremgangsmaade til fremstilling af mikrokapsler
JPH0892129A (ja) * 1993-10-08 1996-04-09 Kanagawa Kagaku Kenkyusho:Kk 眼発作治療薬
JPH07236418A (ja) * 1994-02-25 1995-09-12 Kanegafuchi Chem Ind Co Ltd ドコサヘキサエン酸、エイコサペンタエン酸用抗酸化矯臭剤
NL9401743A (nl) * 1994-10-20 1996-06-03 Prospa Bv Zouten van aminoalcoholen en farmaceutische formuleringen die deze bevatten.
JP3545148B2 (ja) * 1996-01-08 2004-07-21 味の素株式会社 食用マイクロカプセル及びそれを含有する食品
JPH1029938A (ja) * 1996-07-17 1998-02-03 Maruha Corp 虚血性眼疾患の予防および／または治療剤
JP3640005B2 (ja) * 1996-09-25 2005-04-20 日本たばこ産業株式会社 ソフトカプセル用皮膜
JP4028020B2 (ja) * 1997-02-17 2007-12-26 株式会社紀文フードケミファ 動体視力改善剤
JPH10286079A (ja) * 1997-04-16 1998-10-27 Yasumasa Morita 薬草ハーブと不飽和脂肪酸ｄ．ｈ．ａ（ドコサヘキ サエン酸）を混入した海産物海苔
JP4028642B2 (ja) * 1997-10-07 2007-12-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 乳化粉末の製造方法
EP0958828A1 (de) * 1998-05-22 1999-11-24 Greither, Peter Präparat auf der Basis der Artischockenpflanze, insbesondere zur Verwendung als Arzneimittel oder Nahrungsergänzungsmittel
DE19845358A1 (de) * 1998-10-02 2000-04-06 Roehm Gmbh Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe
US6582721B1 (en) * 1999-09-17 2003-06-24 Alcon, Inc. Stable carotene-xanthophyll beadlet compositions and methods of use
US7704542B2 (en) * 2001-09-12 2010-04-27 Xanodyne Pharmaceuticals, Inc. Vitamin/mineral compositions with DHA
DE20205184U1 (de) 2002-03-27 2002-12-19 Bartz Volker Blutfettsenker zur oralen Einnahme
AR039170A1 (es) * 2002-03-28 2005-02-09 Bio Dar Ltd Co-granulos de dha y romero y metodos de uso
US20050147698A1 (en) * 2002-03-28 2005-07-07 Alcon, Inc. Co-beadlet of dha and rosemary and methods of use

Also Published As

Publication number Publication date
AU2003220417A1 (en) 2003-10-13
EP1487418B1 (en) 2008-06-18
CA2478154A1 (en) 2003-10-09
JP2006077024A (ja) 2006-03-23
US20080152710A1 (en) 2008-06-26
EP1487418A1 (en) 2004-12-22
HK1070558A1 (en) 2005-06-24
DE60321669D1 (de) 2008-07-31
AU2003220417B2 (en) 2009-03-12
ATE398445T1 (de) 2008-07-15
DK1487418T3 (da) 2008-09-15
JP2005527551A (ja) 2005-09-15
US20050147698A1 (en) 2005-07-07
EP1487418A4 (en) 2005-07-13
AR039171A1 (es) 2005-02-09
WO2003082249A1 (en) 2003-10-09

Similar Documents

Publication Publication Date Title
BR0308799A (pt) co-glóbulos de dha e alecrim e método de uso
BR0308713A (pt) Co-esférula de dha e alecrim, e métodos de uso
WO2002062751A1 (fr) Nouveaux derives de cystine et inhibiteurs de l'activation des facteurs inflammatoires
TR200201921T2 (tr) İyileştirilmiş pediyatrik formülasyon ve beslenme temin etmek ve tolerans geliştirmek için yöntemler.
DE69829853D1 (de) Nahrungszusammensetzungen enthaltend methionin
BR0317891A (pt) Tratamento de ferimentos de pele usando polienilfosfatidil colina e alcanolaminas
BRPI0415699A (pt) uso de oligossacarìdeo ácido e de oligossacarìdeo neutro, e, composições alimentìcia e lìquida
HK1073996A1 (en) Use of adapalene for the treatment of dermatological disorders
CA2447924A1 (en) Olopatadine formulations for topical administration
MXPA05007516A (es) Derivados de hexahidropirazino[1,2-a]pirimidina -4, 7-diona sustituidos, metodo para producirlos y su uso como medicamentos.
MXPA02004933A (es) Composiciones cosmeticas conteniendo extracto de garbanzo y retinoides.
DE60314722D1 (de) Zusammensetzung für die pharmazeutische oder dietätische verwendung zur bekämpfung von haarausfall
NO20053788D0 (no) Anvendelse av lupin-konglutin for behandlingen av type II diabetes.
AU3142099A (en) Method for providing glutamine
HUP0304077A2 (hu) A bőr öregedése elleni gyógyászati és kozmetikai készítmények
BR0215124A (pt) Compostos e seus usos, composições farmacêutica e cosmética e uso cosmético de uma composição cosmética
BR0312318A (pt) Compostos, uso de um ou mais compostos, composição farmacêutica, composição cosmética e usos cosméticos
WO2006134135A3 (en) Nutritional method for elderly people
DE50113974D1 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
DK1409449T3 (da) Alpha-ketoglutarater af aktive ingredienser og sammensætninger omfattende disse
DE50310932D1 (de) Sporopollenin enthaltende lösliche zusammensetzung und verwendung
AU2003290031A1 (en) Method of improvement of blood circulation
UY27475A1 (es) Amidas de ácido piperazinciclohexanocarboxílico sustituidas y su utilización
BR0212289A (pt) Anticorpos contra caspase-8, preparação e uso do mesmo
AR030945A1 (es) Amidas de acido fenilciclohexanocarboxilico sustituido y su uso

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE A 9A ANUIDADE.